Trade-Ideas LLC identified

Silver Standard Resources

(

SSRI

) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Silver Standard Resources as such a stock due to the following factors:

  • SSRI has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $23.0 million.
  • SSRI has traded 1.3 million shares today.
  • SSRI is up 3.1% today.
  • SSRI was down 6.7% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in SSRI with the Ticky from Trade-Ideas. See the FREE profile for SSRI NOW at Trade-Ideas

More details on SSRI:

Silver Standard Resources Inc. engages in the acquisition, exploration, development, and operation of precious metal resource properties in the Americas. The company primarily explores for gold, silver, zinc, and lead deposits. Currently there are 2 analysts that rate Silver Standard Resources a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for Silver Standard Resources has been 2.2 million shares per day over the past 30 days. Silver Standard has a market cap of $808.4 million and is part of the basic materials sector and metals & mining industry. The stock has a beta of 0.02 and a short float of 1.4% with 2.44 days to cover. Shares are up 79.7% year-to-date as of the close of trading on Wednesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Silver Standard Resources as a

sell

. Among the areas we feel are negative, one of the most important has been weak operating cash flow.

Highlights from the ratings report include:

  • Net operating cash flow has significantly decreased to $12.72 million or 58.69% when compared to the same quarter last year. In addition, when comparing the cash generation rate to the industry average, the firm's growth is significantly lower.
  • The change in net income from the same quarter one year ago has significantly exceeded that of the Metals & Mining industry average, but is less than that of the S&P 500. The net income has significantly decreased by 74.9% when compared to the same quarter one year ago, falling from $9.16 million to $2.30 million.
  • SILVER STANDARD RES INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has not demonstrated a clear trend in earnings over the past 2 years, making it difficult to accurately predict earnings for the coming year. During the past fiscal year, SILVER STANDARD RES INC continued to lose money by earning -$1.55 versus -$1.57 in the prior year.
  • Despite the weak revenue results, SSRI has significantly outperformed against the industry average of 43.5%. Since the same quarter one year prior, revenues slightly dropped by 9.1%. The declining revenue appears to have seeped down to the company's bottom line, decreasing earnings per share.
  • Compared to its closing price of one year ago, SSRI's share price has jumped by 69.16%, exceeding the performance of the broader market during that same time frame. Regarding the future course of this stock, we feel that the risks involved in investing in SSRI do not compensate for any future upside potential, despite the fact that it has seen nice gains over the past 12 months.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.